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 The superovulation protocol was as diagrammed: 
 18 heifers of similar age and body weight from the Iowa State University Dairy 
Teaching Farm were used for this study from March 2016 to October 2016. 
 Heifers were randomly assigned to receive a 7.0 mL injection of the saline 
(CON) or MultiMin90TM (MM) treatment per label dose (1 mL/100 lbs of body 
weight), followed by an industry standard superstimulation protocol (Figure 1, 
Table 1).
 Embryos were recovered on d 17 (7 d after AI). All recovered embryos were 
collected via non-surgical uterine flush and were evaluated according to 
International Embryo Transfer Society standards. Each embryo was given a 
developmental stage (Table 2) and quality grade (Table 3).
 Data were analyzed using the MIXED procedures of SAS with animal as the 
experimental unit. P-values ≤ 0.05 were considered to be significant; whereas 
0.05 < P ≤ 0.15 were considered a tendency.
Supplementation of injectable trace minerals is often used to combat the
malabsorption of microminerals due to antagonists in feed and water. One such
supplement, Multimin90TM, containing copper, zinc, manganese, and selenium, has
recently been shown to have a positive impact on reproductive efficiency and
pregnancy rates. The objective of this study was to determine how the
supplementation of MultiMin90TM impacts embryo quality. We hypothesized that
MultiMin90TM would improve embryo quality, as determined by the assessment of
embryos recovered from ovarian superstimulated donor heifers seven days post-
artificial insemination. Seventeen dairy heifers from the Iowa State University Dairy
Teaching Farm were randomly assigned to receive a saline control (CON) or
Multimin90TM (MM), given at label dose of 1 mL/100 lbs of body weight. All heifers
were then put on an industry standard ovarian superovulation protocol, with embryos
recovered on day 7 after artificial insemination. Embryos were graded for quality and
developmental stage, and data were analyzed using SAS. On average, the proportion
of nonfertilized embryos tended to be greater in CON heifers (P = 0.15), and the
average proportion of Stage 4 (P = 0.11) and Stage 5 (P = 0.11) embryos tended to be
greater in MM heifers. No differences were noted in total embryos recovered as a
result of total treatment (P = 0.51). This concludes that our hypothesis was partially
correct. Though MM did decrease the overall average proportion of nonfertilized
embryos, there was not a significant trend towards increased embryo quality across
the board. However, the results do point towards a biologically relevant trend towards
fewer total nonfertilized embryos and more total transferrable embryos produced
when treated with MM..
• MultiMin90TM is an injectable trace mineral supplement that contains four
minerals: copper, zinc, manganese, and selenium. It is routinely used with the
purpose of balancing critical nutrients in a cow’s diet (“MultiMin90: How Does
It Work?”, 2015). Recently, this supplement has been shown to have a positive
impact on reproductive efficiency and pregnancy rates in beef cattle (Mundell
et al., 2012).
• Dietary deficiency of minerals contained in MultiMin90TM can result in
irregular or suppressed estrus cycles, trouble producing a live calf, and
difficulties during and after calving (“Minerals,” 1996). Moreover, as a
combined injection, these minerals have been shown to increase conception
rates and help the immune system (“Building Your Beef Herd,” 2015).
Improved pregnancy rates could be accomplished through a number of
avenues, including reduced embryonic loss, hormone production, less loss of
pregnancy, or embryo quality; though the exact pathway is still unclear.
• This study focused on the effects of MultiMin90TM on embryo quality through
a superovulation and embryo flushing protocol.
Effects of injectable trace mineral supplementation on embryo development 







The objective of this study was to determine if supplementation of an injectable
trace mineral product would improve embryo quality. We hypothesized that
MultiMin90TM would improve embryo quality, as determined by the assessment
of embryos recovered from ovarian superstimulated dairy heifers seven days
post-artificial insemination.
• There was no effect of treatment on total number of embryos, number of 
transferrable embryos, or number of freezable embryos (P ≥ 0.14; Table 4).
• MM heifers had no differences in the number of Quality Grade 1 embryos (P = 
0.32), but did have greater numbers of Quality Grade 2 (P = 0.08) and Quality 
Grade 3 (P = 0.15) embryos compared to CON (Table 5).
• On average, the proportion of nonfertilized embryos tended to be greater in 
CON heifers than MM heifers (P = 0.15; Table 2). 
• MM heifers tended to have an increased number of Stage 4 embryos (P = 0.09; 
Table 6). On average, the proportion of Stage 4 (P = 0.11) and Stage 5 (P = 
0.11) embryos tended to be greater in MM. This could indicate a synchronous 
ovulation pattern and embryo development pattern.
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FUTURE IMPLICATIONS
• More heifers need to be added to the dataset to strengthen the conclusions and to 
better understand the impact of MM treatment on embryos.
• Once the impact of MM on embryos is understood, further research should study 
which of the four micronutrients in MultiMin90TM is the cause of this impact.
• Future research should also study the timing of the injections to determine if 
there is an appropriate time frame for treatment with MM in a superovulation 
program.
• Our hypothesis was partially correct. Though MM treatment did decrease the 
average proportion of nonfertilized embryos, there is not a significant trend 
towards increased embryo quality overall. However, embryos were more uniform 
in their development.
• Although not statistically significant, the numerical increase in transferrable 
embryos likely has major economic benefit at the producer level.
Day Time Administrations
0 am CIDRTM insertion + 2.5 cc PGF2α + 7.0 cc Saline or 
Multimin
4 am 3.0 cc GnRH
5 pm 2.0 cc FSH
6 am 2.0 cc FSH
6 pm 1.5 cc FSH
7 am 1.5 cc FSH
7 pm 1.5 cc FSH
8 am 1.5 cc FSH
8 pm 1.0 cc FSH + 2.5 cc PGF2α
9 am 1.0 cc FSH + 2.5 cc PGF2α + CIDRTM removal
10 pm AI + 3.0 cc GnRH
11 am AI
17 am Embryo recovery
Table 1. Standard superstimulation protocol used.
Stage Characteristics
1 Unfertilized







9 Expanded hatched blastocyst
Table 2. The International Embryo Transfer Society standards for embryo 
staging.
Quality Grade Characteristics
1: Excellent or Good Uniform, spherical in appearance. 
Minor irregularities in structure. At 
least 85% of cell mass intact and 
viable.
2: Fair Moderate irregularities in structure. 
At least 50% of cell mass intact and 
viable.
3: Poor Many irregularities in structure. At 
least 25% of cell mass intact and 
viable.
4: Dead or Degenerating Oocytes, 1 cell embryos, or 
degenerating embryos.
Table 3. The International Embryo Transfer Society standards for embryo 
quality grade.
Embryo Quality Con1 MM2 SEM3 P-value
Quality 1, no. 2.11 3.38 0.85 0.32
Average Proportion of Flush4, % 38.66 56.98 12.56 0.30
Average Proportion of Transferrable5, % 89.29 76.96 7.64 0.31
Average Proportion of Freezable6, % 88.48 78.70 7.02 0.23
Quality 2, no. 0.24 0.74 0.23 0.08
Average Proportion of Flush4, % 2.87 8.76 2.92 0.17
Average Proportion of Transferrable5, % 11.52 21.30 7.02 0.23
Average Proportion of Freezable6, % 11.52 21.30 7.02 0.23
Quality 3, no. 0.00 0.25 0.11 0.15
Average Proportion of Flush4, % 0.00 8.75 4.37 0.20
Average Proportion of Transferrable5, % 0.00 10.42 6.17 0.29
Quality 4, no. 2.22 1.88 0.92 0.79
Degenerate, no. 0.67 1.25 0.44 0.37
Average Proportion of Flush4, % 17.12 16.66 9.75 0.97
Nonfertilized, no. 1.56 0.63 0.65 0.34
Average Proportion of Flush, % 29.17 6.97 9.65 0.15
Average Proportion of Flush4, % 46.30 23.63 12.18 0.22
1 Control (Saline)
2 Multimin90TM containing 60 mg/mL Zn, 10 mg/mL Mn, 5 mg/mL Se, and 15 
mg/mL Cu
3 n = 9 for MM; n = 8 for CON 
4 of total structures collected, the number of embryos in a given stage
5 of total embryos graded Quality 1-3, proportion that were of given stage
6 of total embryos graded Quality 1-2, proportion that were of given stage
Developmental Stage Con1 MM2 SEM3 P-value
Stage 3, no. 0.00 0.13 0.09 0.29
Average Proportion of Flush4, % -0.10 2.54 1.73 0.29
Stage 4, no. 0.55 1.76 0.45 0.09
Average Proportion of Flush4, % 11.57 34.87 8.88 0.11
Average Proportion of Transferrable5, % 43.73 44.05 17.04 0.99
Average Proportion of Freezable6, % 44.05 46.13 16.97 0.93
Stage 5, no. 0.56 1.13 0.33 0.26
Average Proportion of Flush4, % 6.48 17.97 4.50 0.11
Average Proportion of Transferrable5, % 13.67 24.05 6.39 0.31
Average Proportion of Freezable6, % 12.95 27.77 6.95 0.18
Stage 6, no. 0.78 0.63 0.44 0.81
Average Proportion of Flush4, % 13.43 6.61 6.39 0.47
Average Proportion of Transferrable5, % 24.40 10.36 8.82 0.31
Average Proportion of Freezable6, % 24.40 10.36 8.82 0.31
Stage 7, no. 0.78 0.63 0.44 0.81
Average Proportion of Flush4, % 9.72 1.92 4.69 0.27
Average Proportion of Transferrable5, % 15.93 4.80 6.98 0.30
Average Proportion of Freezable6, % 15.93 4.80 6.98 0.30
Stage 8, no. 0.11 -0.01 0.09 0.34
Average Proportion of Flush4, % 1.41 -0.09 1.09 0.34
Average Proportion of Transferrable5, % 2.39 -0.04 1.54 0.31
Average Proportion of Freezable6, % 2.39 -0.04 1.54 0.31
1 Control (Saline)
2 Multimin90TM containing 60 mg/mL Zn, 10 mg/mL Mn, 5 mg/mL Se, and 15 
mg/mL Cu
3 n = 9 for MM; n = 8 for CON 
4 of total structures collected, the number of embryos in a given stage
5 of total embryos graded Quality 1-3, proportion that were of given stage
6 of total embryos graded Quality 1-2, proportion that were of given stage
Total Embryos Con1 MM2 SEM3 P-value
Total Embryos, no. 4.78 6.00 1.28 0.51
Transferrable Embryos, no. 2.44 4.13 0.88 0.21
Freezable Embryos, no. 2.44 3.88 0.92 0.30
1Control (Saline)
2 Multimin90TM containing 60 mg/mL Zn, 10 mg/mL Mn, 5 mg/mL Se, and 
15 mg/mL Cu
3 n = 9 for MM; n = 8 for CON 
Figure 1. Standard superstimulation protocol diagram.
Table 4. Effects of an injectable trace mineral supplement at initiation of 
superovulation protocol on embryo production in yearling dairy heifers.
Table 5. Effects of an injectable trace mineral supplement at initiation of 
superovulation protocol on embryo quality in yearling dairy heifers.
Table 6. Effects of an injectable trace mineral supplement at initiation of 
superovulation protocol on embryo development in yearling dairy heifers.
